This core component will serve to procure long-term follow-up outcome data from patients who have participated in clinical research studies sponsored by this grant. Additional goals are to assist patients and referring physicians in management of late complications such as chronic GVHD and to assist investigators in obtaining information that is not routinely collected when needed for individual research projects. Follow- up data focused on an ongoing assessment of therapy-related complications will be obtained from two groups of patients. One groups is a population of more than 500 patients who are currently being followed at intervals from less than 1 year to more than 25 years after previous treatment at the FHCRC. The other group will include future patients enrolled in studies described in Projects 1, 3, 4 and 5 of this grant application. Three methods will be used to obtain data. First, a baseline questionnaire will be completed by patients before they return to the care of the referring physician, and comprehensive update questions will be sent to all patients at 6 months and 1 year after treatment and at annual intervals thereafter. Second, a diagnostic checklist will be sent to referring physicians when patients return questionnaires. Third, medical records will be requested from referring physicians. Authorization for access to medical records will be obtained when questionnaires are sent to patients. Key data will be verified by cross-referencing the three sources, and an annotated database will be constructed to summarized information from all three sources. Questionnaire items will be assessed to determine sensitivity and specificity when compared with information from the physician's diagnostic checklist and medical records, and algorithms will be developed to allow tailoring of questionnaires in order to optimize the yield for accurate information form as few items as possible. Access to information in the database will enable investigators to determine the long-term outcome of clinical research studies sponsored by the program.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL036444-21
Application #
6513655
Study Section
Heart, Lung, and Blood Program Project Review Committee (HLBP)
Project Start
1985-07-01
Project End
2006-07-31
Budget Start
Budget End
Support Year
21
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
McCune, Jeannine S; Storer, Barry; Thomas, Sushma et al. (2018) Inosine Monophosphate Dehydrogenase Pharmacogenetics in Hematopoietic Cell Transplantation Patients. Biol Blood Marrow Transplant 24:1802-1807
Thakar, M S; Bonfim, C; Walters, M C et al. (2017) Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemia. Bone Marrow Transplant 52:570-573
Burroughs, Lauri M; Shimamura, Akiko; Talano, Julie-An et al. (2017) Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders. Biol Blood Marrow Transplant 23:1669-1677
Vaughn, J E; Anwer, F; Deeg, H J (2016) Treatment of refractory ITP and Evans syndrome by haematopoietic cell transplantation: is it indicated, and for whom? Vox Sang 110:5-11
Aki, S Z; Inamoto, Y; Carpenter, P A et al. (2016) Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severity. Bone Marrow Transplant 51:1350-1353
Khera, Nandita; Gooley, Ted; Flowers, Mary E D et al. (2016) Association of Distance from Transplantation Center and Place of Residence on Outcomes after Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 22:1319-1323
Karoopongse, Ekapun; Marcondes, A Mario; Yeung, Cecilia et al. (2016) Disruption of Iron Regulation after Radiation and Donor Cell Infusion. Biol Blood Marrow Transplant 22:1173-1181
Hoffmeister, P A; Storer, B E; Syrjala, K L et al. (2016) Physician-diagnosed depression and suicides in pediatric hematopoietic cell transplant survivors with up to 40 years of follow-up. Bone Marrow Transplant 51:153-6
Gallo, S; Woolfrey, A E; Burroughs, L M et al. (2016) Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD? Bone Marrow Transplant 51:1573-1578
Festuccia, Moreno; Deeg, H Joachim; Gooley, Theodore A et al. (2016) Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic Syndrome. Biol Blood Marrow Transplant 22:1227-1233

Showing the most recent 10 out of 788 publications